電子鼻市場規模、シェア、動向、2032年までの世界予測

電子鼻市場は2026年に4億2000万米ドル規模となり、予測期間中に年平均成長率（CAGR）28.0%で成長し、2032年までに18億4000万米ドルに達するとMarketsandMarketsでは予測しています。

MarketsandMarkets（マーケッツアンドマーケッツ）「電子鼻市場 – 用途（品質管理、品質保証）、検査タイプ（インライン、ラボ）、センサータイプ（MOSセンサー、ポリマーセンサー、光学センサー、QCMセンサー、SQWセンサー）、および最終用途産業別 – 2032年までの世界市場予測 – E-nose Market by Application (Quality Control, Quality Assurance), Inspection Type (Inline, Laboratory), Sensor Type (MOS Sensors, Polymer Sensors, Optical Sensors, QCM Sensors, SQW Sensors), and End Use Industry – Global Forecast to 2032」は電子鼻（e-Nose）の世界市場を調査し、主要セグメント別に分析・予測を行っています。

調査対象セグメント

• 検査の種類別電子鼻市場（2031年までの市場規模と予測 – 百万米ドル）
  • インライン検査システム
  • 実験室検査システム
• センサのタイプ別電子鼻市場（2031年までの市場規模と予測 – 百万米ドル）
  • 金属酸化物半導体（MOS）センサー
  • ポリマーセンサー
  • 水晶振動子マイクロバランス（QCM）センサー
  • 表面弾性波（SAW）センサー
  • 光センサー
  • その他の先進センサー
• 用途別電子鼻市場（2031年までの市場規模と予測 – 百万米ドル）
  • 品質管理（品質マネジメント）
  • 品質保証
• 最終用途産業別電子鼻市場（2031年までの市場規模と予測 – 百万米ドル）
  • 食品産業
    • 食肉
    • 家禽
    • 水産物
    • 乳製品
    •  ベーカリー
    • 菓子類
    • ケータリング
    • 調理済み食品
    • その他
  • 医薬品産業
  • 化学産業
    • 化粧品
    • 化学品
• 地域別電子鼻市場（2031年までの市場規模と予測 – 百万米ドル）
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他の欧州
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • オーストラリア＆ニュージーランド
    • その他のアジア太平洋地域
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米
  • その他の地域（RoW）
    • 中東
    • アフリカ

調査対象企業

• SmartNanotubes Technologies GmbH (ドイツ　)
• NOZE (カナダ)
• Alpha MOS (フランス)
• The eNose Company (オランダ)
• AIRSENSE Analytics GmbH (ドイツ)
• Aryballe Technologies (フランス)
• Owlstone Medical Ltd (英国)
• Scentroid (カナダ)
• Sensigent LLC (米国)
• RoboScientific (英国).

調査概要

本レポートは、電子鼻市場をセグメント化し、用途、検査タイプ、センサータイプ、最終用途産業、地域別に予測しています。また、市場における推進要因、阻害要因、機会、課題についても考察しています。北米、欧州、アジア太平洋、南米、中東・アフリカの5つの主要地域における市場の詳細な分析を提供します。さらに、主要企業のバリューチェーン分析と、電子鼻エコシステムにおける競合分析も含まれています。

レポート購入の主なメリット

電子鼻市場の成長に影響を与える主要な推進要因（コールドチェーン物流における自動感覚プロファイリングおよび腐敗検出のためのVOCベースのデジタル嗅覚、予防医療におけるマイクロバイオームおよびVOCシグネチャ検出）、阻害要因（センサーのドリフトと再校正の必要性）、機会（予防医療における呼気ベースの疾患診断）、課題（センサーの摩耗と経年劣化による性能低下、標準化されたVOC検出規制の欠如）の分析

• 製品／ソリューション／イノベーション：電子鼻市場における今後の製品、研究開発活動に関する詳細な洞察
• 市場開発：様々な地域における有望な市場に関する包括的な情報
• 市場の多様化：未開拓地域における新しい電子鼻、最近の動向、電子鼻市場への投資に関する徹底的な情報
• 競合評価：電子鼻市場の主要コンポーネントを提供する主要企業の市場シェア、成長戦略、および製品に関する詳細な評価

Report Description

The E-nose market is estimated to be valued at USD 0.42 billion in 2026 and is projected to reach USD 1.84 billion by 2032, registering a CAGR of 28.0% during the forecast period.

“Growing shift toward preventive monitoring and real-time decision-making to drive growth in the E-nose market.”

The growing shift toward preventive monitoring and real-time decision-making is accelerating growth in the E-nose market. Industries are increasingly moving from reactive testing approaches toward continuous odor analytics and early anomaly detection to improve operational reliability and reduce quality failures. E-nose systems enable rapid identification of VOC changes and process deviations without requiring time-intensive laboratory analysis, making them valuable across food production, pharmaceuticals, industrial operations, and healthcare diagnostics. Additionally, increasing emphasis on reducing waste, minimizing downtime, and improving traceability is driving the adoption of intelligent odor monitoring solutions integrated with AI and connected analytics platforms. This transition toward proactive and data-driven monitoring is expected to create sustained long-term demand for digital scent technologies globally.

“The food industry segment is expected to register the highest CAGR during the forecast period.”

By end-use industry, the food industry segment is expected to register the highest CAGR during the forecast period in the E-nose market, driven by the increasing need for automated quality assurance, food authenticity verification, and real-time freshness monitoring across global food supply chains. E-nose systems are increasingly being adopted to analyze aroma profiles, detect spoilage, identify contamination, and maintain consistency across processed foods, dairy, beverages, meat, and packaged products. Growing consumer demand for safe, premium-quality, and traceable food products, combined with stricter food safety regulations, is accelerating investment in AI-enabled odor inspection technologies. Continuous advancements in sensor performance, predictive analytics, and smart factory integration are further improving production efficiency and reducing dependence on traditional laboratory testing. These technological and regulatory shifts are expected to sustain strong growth momentum for the food industry segment throughout the forecast period.

“The Surface Acoustic Wave (SAW) sensors segment is expected to register the highest CAGR during the forecast period.”

By sensor type, the Surface Acoustic Wave (SAW) sensors segment is expected to register the highest CAGR during the forecast period in the E-nose market, driven by the increasing demand for highly sensitive, rapid-response, and low-concentration VOC detection capabilities across advanced sensing applications. SAW sensors are gaining traction due to their superior detection accuracy, fast signal processing, and ability to identify complex odor signatures in healthcare diagnostics, food quality monitoring, industrial safety, and environmental analysis. Their compatibility with miniaturized device architectures and real-time monitoring platforms makes them increasingly attractive for next-generation digital scent systems. Continuous advancements in sensor materials, wireless connectivity, and AI-enabled signal interpretation are further enhancing performance and expanding commercial adoption. These technological advantages are expected to accelerate the deployment of SAW-based E-nose solutions throughout the forecast period.

“North America to dominate the pharmaceutical E-nose market in 2026.”

North America is projected to account for the largest market share of the pharmaceutical E-nose market in 2026, driven by increasing adoption of advanced analytical technologies for pharmaceutical quality control, manufacturing optimization, and laboratory automation. The region benefits from a strong pharmaceutical and biotechnology industry base, significant R&D spending, and growing use of VOC analysis for raw material verification, process monitoring, and contamination assessment. In addition, stringent regulatory expectations around product quality and manufacturing consistency are encouraging pharmaceutical companies to adopt faster and more data-driven analytical approaches. Continuous investments in digital laboratories, analytical instrumentation, and AI-enabled sensing technologies are expected to support North America’s leadership position in the pharmaceutical E-nose market.

Breakdown of Primaries

Various executives from key organizations operating in the E-nose market were interviewed in-depth, including CEOs, marketing directors, and innovation and technology directors.

• By Company Type: Tier 1 – 40%, Tier 2 – 30%, and Tier 3 – 30%
• By Designation: Directors – 20%, Managers – 10%, and Others – 70%
• By Region: Asia Pacific – 45%, Europe – 22%, North America – 22%, and Rest of the World – 11%

The E-nose market is dominated by SmartNanotubes Technologies GmbH (Germany), NOZE (Canada), Alpha MOS (France), The eNose Company (Netherlands), AIRSENSE Analytics GmbH (Germany), Aryballe Technologies (France), Owlstone Medical Ltd (UK), Scentroid (Canada), Sensigent LLC (US), and RoboScientific (UK).

Study Coverage

The report segments the E-nose market and forecasts its application, inspection type, sensor type, end-use industry, and region. The report also discusses the drivers, restraints, opportunities, and challenges pertaining to the market. It provides a detailed view of the market across five main regions—North America, Europe, Asia Pacific, South America, and the Middle East & Africa. The report includes a value chain analysis of the key players and their competitive analysis of the E-nose ecosystem.

Key Benefits of Buying the Report

Analysis of key drivers (VOC-based digital olfaction for automated sensory profiling and spoilage detection in cold chain logistics, microbiome and VOC signature detection in preventive healthcare), restraints (Sensor drift and recalibration requirements), opportunities (Breath-based disease diagnostics in preventive healthcare, and challenges (Performance decline with sensor wear and age, lack of standardized VOC detection regulations), influencing the growth of the E-nose market

• Products/Solutions/Innovation: Detailed insights into upcoming products, research, and development activities in the E-nose market
• Market Development: Comprehensive information about lucrative markets across varied regions
• Market Diversification: Exhaustive information about new E-nose in untapped geographies, recent developments, and investments in the E-nose market
• Competitive Assessment: In-depth assessment of market shares and growth strategies, and offerings of leading players offering components of the E-nose market

Table of Contents

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
1.3.2 INCLUSIONS AND EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.4 UNIT CONSIDERED
1.5 STAKEHOLDERS

2 EXECUTIVE SUMMARY

2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
2.3 DISRUPTIVE TRENDS IN E-NOSE MARKET
2.4 HIGH-GROWTH SEGMENTS
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

4 MARKET OVERVIEW

4.1 INTRODUCTION
4.2 MARKET DYNAMICS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.2.4 CHALLENGES
4.3 UNMET NEEDS AND WHITE SPACES
4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

5.1 PORTER’S FIVE FORCES ANALYSIS
5.1.1 INTENSITY OF COMPETITIVE RIVALRY
5.1.2 THREAT OF NEW ENTRANTS
5.1.3 THREAT OF SUBSTITUTES
5.1.4 BARGAINING POWER OF SUPPLIERS
5.1.5 BARGAINING POWER OF BUYERS
5.2 MACROECONOMIC OUTLOOK5.3 VALUE CHAIN ANALYSIS
5.4 ECOSYSTEM ANALYSIS
5.5 PRICING ANALYSIS
5.6 TRADE ANALYSIS
5.7 KEY CONFERENCES & EVENTS IN 2026–2027
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.9 INVESTMENT AND FUNDING SCENARIO
5.10 CASE STUDY ANALYSIS
5.11 IMPACT OF 2025 US TARIFF – E-NOSE MARKET
5.11.1 INTRODUCTION
5.11.2 KEY TARIFF RATES
5.11.3 PRICE IMPACT ANALYSIS
5.11.4 IMPACT ON COUNTRY/REGION
5.11.5 IMPACT ON END-USE INDUSTRIES

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVE IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

6.1 KEY TECHNOLOGIES
6.2 COMPLEMENTARY TECHNOLOGIES
6.3 ADJACENT TECHNOLOGIES
6.4 PATENT ANALYSIS
6.4.1 LIST OF MAJOR PATENTS PERTAINING TO MARKET
6.5 FUTURE APPLICATIONS
6.6 IMPACT OF GEN AI ON E-NOSE INDUSTRY
6.6.1 INTRODUCTION
6.6.2 USE OF GEN AI IN E-NOSE INDUSTRY
6.6.3 CASE STUDY ANALYSIS
6.6.4 IMPACT ON E-NOSE MARKET
6.6.5 ADJACENT ECOSYSTEM WORKING ON GEN AI
6.7 SUCCESS STORIES AND REAL-WORLD APPLICATIONS

7 REGULATORY AND SUSTAINABILITY INITIATIVES

7.1 REGIONAL REGULATIONS
7.2 SUSTAINABILITY INITIATIVES
7.3 CERTIFICATIONS, LABELING, & ECO-STANDARDS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

8.1 DECISION-MAKING PROCESS
8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA
8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
8.5 MARKET PROFITABILITY

9 E-NOSE MARKET, BY INSPECTION TYPE (MARKET SIZE & FORECAST TO 2031 – USD MILLION)

9.1 INTRODUCTION
9.2 INLINE INSPECTION SYSTEMS
9.3 LABORATORY INSPECTION SYSTEMS

10 E-NOSE MARKET, BY SENSOR TYPE (MARKET SIZE & FORECAST TO 2031 – USD MILLION)

10.1 INTRODUCTION
10.2 METAL OXIDE SEMICONDUCTOR (MOS) SENSORS
10.3 POLYMER SENSORS
10.4 QUARTZ CRYSTAL MICROBALANCE (QCM) SENSORS
10.5 SURFACE ACOUSTIC WAVE (SAW) SENSORS
10.6 OPTICAL SENSORS
10.7 OTHER ADVANCED SENSORS

11 E-NOSE MARKET, BY APPLICATION (MARKET SIZE & FORECAST TO 2031 – USD MILLION)

11.1 INTRODUCTION
11.2 QUALITY CONTROL (QUALITY MANAGEMENT)
11.3 QUALITY ASSURANCE

12 E-NOSE MARKET, BY END USE INDUSTRY (MARKET SIZE & FORECAST TO 2031 – USD MILLION)

12.1 INTRODUCTION
12.2 FOOD INDUSTRY
12.2.1 MEAT
12.2.2 POULTRY
12.2.3 SEAFOOD
12.2.4 DAIRY
12.2.5 BAKERY
12.2.6 CONFECTIONERY
12.2.7 CATERING
12.2.8 READY-TO-EAT MEALS
12.2.9 OTHERS
12.3 PHARMACEUTICALS INDUSTRY
12.4 CHEMICALS INDUSTRY
12.4.1COSMETICS
12.4.2 CHEMICALS

13 E-NOSE MARKET, BY REGION (MARKET SIZE & FORECAST TO 2031 – USD MILLION)

ASSESSING MARKET POTENTIAL AND GROWTH PATTERNS ACROSS KEY GEOGRAPHIES AND COUNTRIES

13.1 NORTH AMERICA
13.1.1 US
13.1.2 CANADA
13.1.3 MEXICO
13.2 EUROPE
13.2.1 GERMANY
13.2.2 UK
13.2.3 FRANCE
13.2.4 SPAIN
13.2.5 ITALY
13.2.7 REST OF EUROPE
13.3 ASIA PACIFIC
13.3.1 CHINA
13.3.2 JAPAN
13.3.3 INDIA
13.3.4 AUSTRALIA & NEW ZEALAND
13.3.5 REST OF ASIA PACIFIC
13.4 SOUTH AMERICA
13.4.1 BRAZIL
13.4.2 ARGENTINA
13.4.3 REST OF SOUTH AMERICA
13.5 REST OF THE WORLD
13.5.1 MIDDLE EAST
13.5.2 AFRICA

14 COMPETITIVE LANDSCAPE

STRATEGIC ASSESSMENT OF LEADING PLAYERS, MARKET SHARE, REVENUE ANALYSIS, COMPANY POSITIONING, AND COMPETITIVE BENCHMARKS INFLUENCING MARKET POTENTIAL

14.1 OVERVIEW
14.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN, 2022–2025
14.4 MARKET SHARE ANALYSIS, 2025
14.5 BRAND/PRODUCT COMPARISON
14.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
14.7.1 STARS
14.7.2 EMERGING LEADERS
14.7.3 PERVASIVE PLAYERS
14.7.4 PARTICIPANTS
14.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025

15 COMPANY PROFILES

IN-DEPTH REVIEW OF COMPANIES, PRODUCTS, RECENT INITIATIVES, AND POSITIONING STRATEGIES IN THE E-NOSE MARKET LANDSCAPE

15.1 KEY PLAYERS
15.1.1 ALPHA MOS
15.1.2 ARYBALLE
15.1.3 AIRSENSE ANALYTICS GMBH
15.1.4 SENSIGENT LLC
15.1.5 SMARTNANOTUBES
15.1.6 SCENTROID
15.1.7 OLORAMA TECHNOLOGY
15.1.8 ROBOSCIENTIFIC
15.1.9 COMON INVENT B.V.
15.1.10 PLASMION

16 RESEARCH METHODOLOGY

16.1 RESEARCH DATA
16.1.1 SECONDARY DATA
16.1.1.1 Key data from secondary sources
16.1.2 PRIMARY DATA
16.1.2.1 Key data from primary sources
16.1.2.2 Key industry insights
16.1.2.3 Breakdown of primaries
16.2 MARKET SIZE ESTIMATION
16.2.1 BOTTOM-UP APPROACH
16.2.1.1 Approach for capturing market share by bottom-up analysis
16.2.2 TOP-DOWN APPROACH
16.2.2.2 Approach for capturing market share by top-up analysis
16.3 MARKET BREAKDOWN AND DATA TRIANGULATION
16.4 RESEARCH ASSUMPTIONS
16.5 RISK ASSESSMENT
16.6 LIMITATIONS

18 APPENDIX

---

---